Revolution Medicines (RVMD) Return on Sales (2019 - 2025)
Historic Return on Sales for Revolution Medicines (RVMD) over the last 7 years, with Q3 2025 value amounting to 26.71%.
- Revolution Medicines' Return on Sales rose 7909400.0% to 26.71% in Q3 2025 from the same period last year, while for Sep 2025 it was 84.09%, marking a year-over-year increase of 8483200.0%. This contributed to the annual value of 37.68% for FY2023, which is 306500.0% down from last year.
- Revolution Medicines' Return on Sales amounted to 26.71% in Q3 2025, which was up 7909400.0% from 764.23% recorded in Q3 2024.
- In the past 5 years, Revolution Medicines' Return on Sales registered a high of 26.71% during Q3 2025, and its lowest value of 764.23% during Q3 2024.
- In the last 5 years, Revolution Medicines' Return on Sales had a median value of 11.19% in 2023 and averaged 119.46%.
- Its Return on Sales has fluctuated over the past 5 years, first crashed by -7515700bps in 2024, then surged by 7909400bps in 2025.
- Revolution Medicines' Return on Sales (Quarter) stood at 5.57% in 2021, then skyrocketed by 34bps to 3.69% in 2022, then tumbled by -5806bps to 217.7% in 2023, then crashed by -251bps to 764.23% in 2024, then soared by 103bps to 26.71% in 2025.
- Its Return on Sales stands at 26.71% for Q3 2025, versus 764.23% for Q3 2024 and 699.74% for Q2 2024.